🔎 Trials Near Me

Inicio › Cáncer de pulmón de células pequeñas › Nueva Jersey

Ensayos clínicos de Cáncer de pulmón de células pequeñas en Nueva Jersey

17 estudios sobre Cáncer de pulmón de células pequeñas buscan participantes en Nueva Jersey.

Ciudades en Nueva Jersey

Texto oficial del estudio (inglés)

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06586957

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen., Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07476287

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07365241

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  • United Theranostics, Princeton
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07278479

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute of New Jersey, New Brunswick
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07488676

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  • Astera Cancer Care, East Brunswick
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07625644

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06780137

A Study of Armored CAR T Cells in People With Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07783477

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute, New Brunswick
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07057791

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  • Regional Cancer Care Associates, Belleville
  • John Theurer Cancer Center at Hackensack UMC, Hackensack
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Hackensack University Medical Center, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT07488923

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06807632

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Astera Cancer Care, East Brunswick
  • Hackensack Meridian Health Jsumc, Neptune City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT06203210

A Study of LY4175408 in Participants With Advanced Cancer

  • John Theurer Cancer Center At Hackensack UMC, Hackensack
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT07046923

A Study of Hospital-at-Home for People Receiving Tarlatamab

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06957314

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  • Memorial Sloan Kettering at Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT05419076

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Englewood Hospital and Medical Center (site 202), Englewood
  • Summit Medical Group (site 205), Florham Park
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.